Back to results
US 2023/0149540 A1Published application
Vaccine platform for the induction of systemic immune responses
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsThomas L. Cherpes, Rodolfo D. Vicetti Miguel
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided relating to vaccine formulations comprising (i) an agent that specifically binds to CD244; (ii) an effective dose of an antigen; and (iii) an adjuvant, which adjuvant can be, without limitation, an activator of innate-like T cells.
Claims22
A vaccine composition comprising:
- (i) an agent that specifically binds to CD244;
- (ii) an effective dose of an antigen;
- and (iii) an adjuvant.
Dependencies are inferred from the claim text.